Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (36)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Quittner, A. L.
Right arrow Articles by Henry, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quittner, A. L.
Right arrow Articles by Henry, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Pediatric Psychology, Vol. 25, No. 6, 2000, pp. 403-414
© 2000 Society of Pediatric Psychology

Translation and Linguistic Validation of a Disease-Specific Quality of Life Measure for Cystic Fibrosis

Alexandra L. Quittner, PhD1, Sheri Sweeny, MA2, Marc Watrous, PhD3, Paul Munzenberger, PharmD4, Karen Bearss, MS1, Amy Gibson Nitza, MA5, Lisa A. Fisher, BS1 and Bernadette Henry6

1 University of Florida, 2 Research Triangle Institute, 3 Genentech, Inc., 4 Wayne State University, 5 Indiana University, 6 Arcos, Arcos, France

All correspondence should be sent to Alexandra L. Quittner, Dept. of Clinical & Health Psychology, University of Florida, 1600 SW Archer Rd., DG-98, Gainesville, Florida 32610-0165. E-mail: Aquittne{at}hp.ufl.edu .

Objective: To develop a conceptually and semantically valid English version of a French disease-specific measure of quality of life for children, adolescents, and adults with cystic fibrosis (CF).

Methods: Following a backward and forward translation of the measure, 60 participants, including 20 children, 20 parents, and 20 adolescents/young adults completed the Cystic Fibrosis Questionnaire (CFQ) and a series of cognitive probes evaluating their understanding of the items and response choices.

Results: Semantic and conceptual problems with the items were identified and modified for the second set of cognitive interviews. Response distributions across items and ages were adequate, and the predicted associations between disease severity and quality of life were obtained.

Conclusions: The English version of the CFQ appears to be a linguistically valid measure of quality of life for patients with CF. A national validation study is now under way to test the psychometric properties of the measure.

Key words: cystic fibrosis; quality of life; methodology; pediatric psychology.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch. Dis. Child.Home page
H A Hutchings, P Upton, W-Y Cheung, A Maddocks, C Eiser, J G Williams, I T Russell, S Jackson, and M E M Jenney
Adaptation of the Manchester-Minneapolis Quality of Life instrument for use in the UK population
Arch. Dis. Child., October 1, 2007; 92(10): 855 - 860.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
M. Rosenfeld
An Overview of Endpoints for Cystic Fibrosis Clinical Trials: One Size Does Not Fit All
Proceedings of the ATS, August 1, 2007; 4(4): 299 - 301.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
C. H. Goss and A. L. Quittner
Patient-reported Outcomes in Cystic Fibrosis
Proceedings of the ATS, August 1, 2007; 4(4): 378 - 386.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. A. Riekert, S. J. Bartlett, M. P. Boyle, J. A. Krishnan, and C. S. Rand
The Association Between Depression, Lung Function, and Health-Related Quality of Life Among Adults With Cystic Fibrosis
Chest, July 1, 2007; 132(1): 231 - 237.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
D. Schnabel, C. Grasemann, D. Staab, H. Wollmann, F. Ratjen, and for the German Cystic Fibrosis Growth Hormone Stud
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Metabolic and Respiratory Effects of Growth Hormone in Children With Cystic Fibrosis
Pediatrics, June 1, 2007; 119(6): e1230 - e1238.
[Abstract] [Full Text] [PDF]


Home page
Hispanic Journal of Behavioral SciencesHome page
R. P. Agans, N. Deeb-Sossa, and W. D. Kalsbeek
Mexican Immigrants and the Use of Cognitive Assessment Techniques in Questionnaire Development
Hispanic Journal of Behavioral Sciences, May 1, 2006; 28(2): 209 - 230.
[Abstract] [PDF]


Home page
Eur Respir JHome page
D. J. Serisier, J. K. Shute, P. M. Hockey, B. Higgins, J. Conway, and M. P. Carroll
Inhaled heparin in cystic fibrosis
Eur. Respir. J., February 1, 2006; 27(2): 354 - 358.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. R. Elkins, M. Robinson, B. R. Rose, C. Harbour, C. P. Moriarty, G. B. Marks, E. G. Belousova, W. Xuan, P. T.P. Bye, and the National Hypertonic Saline in Cystic Fibrosis
A Controlled Trial of Long-Term Inhaled Hypertonic Saline in Patients with Cystic Fibrosis
N. Engl. J. Med., January 19, 2006; 354(3): 229 - 240.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. H. Donaldson, W. D. Bennett, K. L. Zeman, M. R. Knowles, R. Tarran, and R. C. Boucher
Mucus Clearance and Lung Function in Cystic Fibrosis with Hypertonic Saline
N. Engl. J. Med., January 19, 2006; 354(3): 241 - 250.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. L. Quittner, A. Buu, M. A. Messer, A. C. Modi, and M. Watrous
Development and Validation of the Cystic Fibrosis Questionnaire in the United States: A Health-Related Quality-of-Life Measure for Cystic Fibrosis
Chest, October 1, 2005; 128(4): 2347 - 2354.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. G. Liou, F. R. Adler, and D. Huang
Use of Lung Transplantation Survival Models to Refine Patient Selection in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., May 1, 2005; 171(9): 1053 - 1059.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. H. C. Klijn, A. Oudshoorn, C. K. van der Ent, J. van der Net, J. L. Kimpen, and P. J. M. Helders
Effects of Anaerobic Training in Children With Cystic Fibrosis: A Randomized Controlled Study
Chest, April 1, 2004; 125(4): 1299 - 1305.
[Abstract] [Full Text] [PDF]


Home page
J Pediatr PsycholHome page
A. C. Modi and A. L. Quittner
Validation of a Disease-Specific Measure of Health-Related Quality of Life for Children with Cystic Fibrosis
J. Pediatr. Psychol., December 1, 2003; 28(8): 535 - 546.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
L. Saiman, B. C. Marshall, N. Mayer-Hamblett, J. L. Burns, A. L. Quittner, D. A. Cibene, S. Coquillette, A. Y. Fieberg, F. J. Accurso, and P. W. Campbell III
Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa: A Randomized Controlled Trial
JAMA, October 1, 2003; 290(13): 1749 - 1756.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. Goldbeck, T. G. Schmitz, G. Henrich, and P. Herschbach
Questions on Life Satisfaction for Adolescents and Adults With Cystic Fibrosis: Development of a Disease-Specific Questionnaire
Chest, January 1, 2003; 123(1): 42 - 48.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. T. Britto, U. R. Kotagal, R. W. Hornung, H. D. Atherton, J. Tsevat, and R. W. Wilmott
Impact of Recent Pulmonary Exacerbations on Quality of Life in Patients With Cystic Fibrosis
Chest, January 1, 2002; 121(1): 64 - 72.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
T. G. Liou, F. R. Adler, B. C. Cahill, S. C. FitzSimmons, D. Huang, J. R. Hibbs, and B. C. Marshall
Survival Effect of Lung Transplantation Among Patients With Cystic Fibrosis
JAMA, December 5, 2001; 286(21): 2683 - 2689.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.